CSI Market
Sign In | Register

Moderna Inc (MRNA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access MRNA quarterly Cash Flow →
A period-by-period view of cash flow from Moderna Inc to Dec 31 2021 helps clarify how Dec 31 2025's cash position has changed over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-2,822.00
Depreciation & amortization215.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Ongoing Project0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-34.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation483.00
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions8.00
Gains (Losses) on Extinguishment of Debt0.00
Investment Income Net Amortization Of Discount And Premium-67.00
Increase Decrease In Deferred Rent Credit-
Increase Decrease In Contract With Customer Liability41.00
Increase Decrease In Operating Leases Right Of Use Assets-
Deferred Income Tax Expense Benefit Net-
Increase Decrease In Right Of Use Asset Operating Leases38.00
Income taxes0.00
Gain (Loss) on Sale of Leased Assets, Net, Operating Leases0.00
Increase (Decrease) in Accounts Receivable156.00
Increase (Decrease) in Accounts Payable-92.00
Increase (Decrease) in Accrued Liabilities-2.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets153.00
Other Working Capital-6.00
Other Noncash Income (Expense)77.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-21.00
Discontinued operations0.00
Net Cash flow from Operating Activities-1,873.00
Investing Activities
Capital Expenditures-202.00
Sale of Capital Items0.00
Short-term Investments Proceeds7,916.00
Payments to Acquire Available-for-sale Securities, Debt-5,768.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments to Acquire Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities1,946.00
Financing Activities
Short-term debt Net600.00
Other borrowing transactions-22.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock33.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1,929.00
Reimbursement Of Assets From Lease Financing Obligation-
Payments For Lease Financing Obligation-
Charges To Financing Lease Liabilities-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents1,929.00
Finance Lease Principal Payments-
Finance Lease Principal Payments Net Of Adjustments-18.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities593.00
Effect of exchange rate on cash flow2.00
Discontinued operations0.00
Free Cash Flow-2,075.00
Total Cash Flow668.00
4 historic quarters locked

Sign in to unlock the full Moderna Inc cash flow history.

Sign In Create Free Account

About Moderna Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 20, 2026
  • Source: mrna-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001682852-26-000033

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License